Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9,747 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Batoclimab vs Placebo for Generalized Myasthenia Gravis: A Randomized Clinical Trial.
Yan C, Yue Y, Guan Y, Bu B, Ke Q, Duan R, Deng H, Xue Q, Jiang H, Xiao F, Yang H, Chang T, Zou Z, Li H, Tan S, Xiao H, Zhou H, Zhang H, Meng Q, Li W, Li W, Guo J, Zhang Y, Li Z, Tu J, Shi J, Li W, Lee M, Chen Y, Tao X, Zhao S, Li P, Zhao C; Batoclimab Study Team. Yan C, et al. Among authors: deng h. JAMA Neurol. 2024 Mar 4;81(4):336-45. doi: 10.1001/jamaneurol.2024.0044. Online ahead of print. JAMA Neurol. 2024. PMID: 38436998
Tacrolimus in the treatment of myasthenia gravis in patients with an inadequate response to glucocorticoid therapy: randomized, double-blind, placebo-controlled study conducted in China.
Zhou L, Liu W, Li W, Li H, Zhang X, Shang H, Zhang X, Bu B, Deng H, Fang Q, Li J, Zhang H, Song Z, Ou C, Yan C, Liu T, Zhou H, Bao J, Lu J, Shi H, Zhao C. Zhou L, et al. Among authors: deng h. Ther Adv Neurol Disord. 2017 Sep;10(9):315-325. doi: 10.1177/1756285617721092. Epub 2017 Jul 26. Ther Adv Neurol Disord. 2017. PMID: 28861121 Free PMC article.
A multicenter, randomized, open-label, phase 2 clinical study of telitacicept in adult patients with generalized myasthenia gravis.
Yin J, Zhao M, Xu X, Zhang M, Xu Z, Li Z, Qin X, Li Z, Zhao C, Zhou H, Ma Y, Cao W, Wang G, Lin Y, Zhang J, Zhang X, Cai H, Qian W, Wang Y, Zhang X, Liu G, Wang J, Qiu W, Min L, Li J, Deng H, Chu L, Zhang Y, Fang J. Yin J, et al. Among authors: deng h. Eur J Neurol. 2024 Aug;31(8):e16322. doi: 10.1111/ene.16322. Epub 2024 May 10. Eur J Neurol. 2024. PMID: 38726639 Free PMC article. Clinical Trial.
Efgartigimod for generalized myasthenia gravis: A multicenter real-world cohort study in China.
Luo S, Jiang Q, Zeng W, Wang Q, Zou Z, Yu Y, Hong D, Zeng Q, Tan S, Zhang Z, Zhang Y, Guo X, Chen J, Zhao Z, Huang S, Shi J, Chen Y, Du L, Yan C, Xi J, Song J, Zhao C; Chinese Myasthenia Gravis Collaborating Group (CMGCG). Luo S, et al. Ann Clin Transl Neurol. 2024 Aug;11(8):2212-2221. doi: 10.1002/acn3.52142. Epub 2024 Jul 7. Ann Clin Transl Neurol. 2024. PMID: 38973109 Free PMC article.
Response to rituximab in an anti-muscle-specific receptor tyrosine kinase- and anti-acetylcholine recepto-double-positive myasthenia gravis patient concomitant with follicular dendritic cell sarcoma.
Wang J, Wu X, Deng H, Liu Y, Liu H, Fan X, Liu K, Wu J, Zhang HL. Wang J, et al. Among authors: deng h. Neurosciences (Riyadh). 2016 Jan;21(1):77-8. doi: 10.17712/nsj.2016.1.20150483. Neurosciences (Riyadh). 2016. PMID: 26818174 Free PMC article. No abstract available.
9,747 results